Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Weiss

Showing results (171-180 of 173) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 173 results.
The Journal of Cell Biology|June 2, 1997
An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell functionJ M Weiss, J Sleeman, A C Renkl, et al.
Brain Research. Brain Research Reviews|February 1, 1997
The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactionsB S McEwen, C A Biron, K W Brunson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trialJ M Weiss, T Csoszi, M Maglakelidze, et al.
Pageof 18

Showing results (171-180 of 173) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 173 results.
The Journal of Cell Biology|June 2, 1997
An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell functionJ M Weiss, J Sleeman, A C Renkl, et al.
Brain Research. Brain Research Reviews|February 1, 1997
The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactionsB S McEwen, C A Biron, K W Brunson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trialJ M Weiss, T Csoszi, M Maglakelidze, et al.
Pageof 18